Statement in Response to COVID-19 from Nuventra Pharma Sciences
Durham, NC – As a company committed to helping our clients bring new medicines to patients in need, we have been closely monitoring the global spread of the novel coronavirus…
Read More
Nuventra’s Brian Furmanski to Speak at the Drug Metabolism Discussion Group Winter Symposium
Nuventra’s Brian Furmanski, PhD, will be speaking at this year’s Drug Metabolism Discussion Group (DMDG) Winter Symposium on February 27th at the Solution Center in Research Triangle Park, NC. Brian’s…
Read More
Nuventra to Speak at PBSS San Francisco Symposium: Development of Drug/Device Combinations
Nuventra’s VP of Clinical Pharmacology and Pharmacokinetics, Mark Bush, Ph.D., will be presenting at the next PBSS San Francisco Symposium titled, “Development of Drug/Device Combinations.” Dr. Bush will lead a…
Read More
Nuventra Sponsors Two ASCPT Student Education Scholarships
Nuventra is pleased to announce the sponsorship of two student member’s education grants for the ASCPT 2020 Annual Meeting to support registration fees and travel expenses. The American Society for…
Read More
Former FDA Reviewer Iftekhar Mahmood, Ph.D., Joins Nuventra Pharma Sciences as Senior Consultant
Nuventra Pharma Sciences is pleased to announce the addition of Iftekhar Mahmood, Ph.D., to its growing team of experienced consultants. Dr. Mahmood has more than 25 years of clinical pharmacology…
Read More
Nuventra Pharma Sciences Named a TBJ Fast 50 Award Winner for Fourth Consecutive Year
Nuventra Pharma Sciences is pleased to announce that it has been ranked as a part of the Triangle Business Journal’s Fast 50 List honoring the 50 fastest growing privately held…
Read More
Nuventra’s Brian Furmanski to Present at AACP/AAPS Webinar, “Navigating and Understanding FDA Review Documents”
Nuventra’s Brian Furmanski, PhD, will present during the upcoming AACP and AAPS sponsored webinar titled, “Navigating and Understanding FDA Review Documents.” The webinar will take place on Thursday, October 24…
Read More